ResearchInvestigating Endogenous Hypercortisolism Prevalence in a U.S. Population With Resistant Hypertension: MOMENTUM Rationale and Design
ResearchCardiometabolic Parameter Change by Weight Regain on Tirzepatide Withdrawal in Adults With Obesity: A Post Hoc Analysis of the SURMOUNT-4 Trial.
ResearchInaccurate information regarding cardiovascular disease prevention enabled by generative artificial intelligence.
ResearchBeyond Diabetes: A Review of Emerging Indications for Glucagon-Like Peptide-1 Receptor Agonists.
ResearchIn vivo gene editing for lipid management: An early perspective from ANGPTL3-targeted CRISPR-Cas9 therapy.
ResearchInvestigating Endogenous Hypercortisolism Prevalence in a U.S. Population With Resistant Hypertension: MOMENTUM Rationale and Design.
ResearchAldosterone synthase inhibitors for hypertension: A breakthrough facing barriers to adoption.
Mar 19, 2026Journal ArticleAngiotensinogen Reconsidered: Evolving Perspectives in Hypertension Research.Written by 1 Roon author & 4 others Via The American Heart Association Journals
ResearchEndothelial triple-pathway vasorelaxation as an adjunctive strategy in resistant hypertension.
ResearchInvestigating Endogenous Hypercortisolism Prevalence in a U.S. Population With Resistant Hypertension: MOMENTUM Rationale and Design